Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexeo Therapeutics, Inc. - Common Stock
(NQ:
LXEO
)
7.450
-0.670 (-8.25%)
Streaming Delayed Price
Updated: 3:38 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexeo Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
Keep an eye on the top gainers and losers in Monday's session.
↗
January 12, 2026
Via
Chartmill
Top stock movements in today's session.
↗
January 12, 2026
Via
Chartmill
Gapping stocks in Monday's session
↗
January 12, 2026
Via
Chartmill
Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In
↗
October 08, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 07, 2025
Via
Benzinga
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process
↗
October 07, 2025
Via
Stocktwits
James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday
↗
October 07, 2025
Via
Benzinga
Tuesday's session: gap up and gap down stocks
↗
October 07, 2025
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 07, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 24, 2025
Via
Benzinga
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals
↗
September 04, 2025
FDA launches Rare Disease Evidence Principles to guide therapy reviews, offering new pathways for approval while raising questions on development impact.
Via
Benzinga
Lexeo Reports Q2 Loss as Costs Jump 129%
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
↗
July 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 09, 2025
Via
Benzinga
Which stocks are moving on Monday?
↗
April 07, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Keep an eye on the top gainers and losers in Monday's session.
↗
April 07, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 07, 2025
Via
Benzinga
Monday's session: gap up and gap down stocks
↗
April 07, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Gene Therapy For Fatal Rare Disease-Associated Heart Condition - Lexeo Therapeutics Candidate Shows Improvements In Trials
↗
April 07, 2025
Lexeo reported strong interim results for LX2006 in ataxia cardiomyopathy, with plans to start a registrational study by early 2026.
Via
Benzinga
Pharma Frenzy: Volatility Ignites Biotech Sector
March 25, 2025
Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.
Via
MarketBeat
Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw?
↗
March 25, 2025
The company reported an adjusted Q4 loss of $0.78 per share, beating expectations for a $0.81 loss.
Via
Stocktwits
What's going on in today's session
↗
March 24, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 24, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
↗
March 24, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
February 20, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 13, 2024
Via
Benzinga
LXEO Stock Earnings: Lexeo Therapeutics Beats EPS for Q2 2024
↗
August 12, 2024
LXEO stock results show that Lexeo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
